Indicated for: diagnostic imaging contrast enhancement
Route of administration: injectable
Substance: ferucarbotran (contrast agent)
ATC: V08CB03 (Various | Magnetic resonance imaging contrast media | Superparamagnetic contrast media)
Ferucarbotran is an iron-based contrast agent used in magnetic resonance imaging (MRI), especially for evaluating the liver and spleen. This medication helps obtain clearer images, making it easier to diagnose certain liver or tumor conditions.
Ferucarbotran is administered by intravenous injection under medical supervision. The dose is determined by the doctor based on the patient's weight and needs. It is important to inform your doctor about any allergies or health problems before administration.
Common side effects include reactions at the injection site, nausea, headache, or temporary changes in taste. In rare cases, severe allergic reactions or breathing difficulties may occur. If you experience any unusual symptoms, contact medical staff immediately.
Ferucarbotran is a valuable tool for the accurate diagnosis of liver conditions, but its use requires careful medical supervision. Always inform your doctor about any other treatments or existing health conditions.